查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2047967

真菌蛋白市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、性質、應用、地區和競爭格局分類，2021-2031年

Fungal Protein Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Nature, By Application By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球真菌蛋白市場預計將從 2025 年的 41.1 億美元大幅成長至 2031 年的 58.7 億美元，複合年成長率為 6.12%。

真菌蛋白是一種永續的食品配料，透過發酵鐮刀菌（Fusarium v​​ienatum）等真菌生產，可作為肉類的纖維替代品。這項市場擴張的主要驅動力是全球對資源高效型食品體係日益成長的需求，以及消費者對符合道德規範的非動物性蛋白質的偏好不斷增強。這些因素代表著全球食品供應的持續結構性轉變，而非曇花一現的市場趨勢。例如，良好食品研究所（Good Food Institute）的數據顯示，到2025年，約有50%的法國消費者將青睞微發酵產品，凸顯了該品類不斷擴大的商業性潛力。

市場概覽
預測期 2027-2031
市場規模：2025年 41.1億美元
市場規模：2031年 58.7億美元
複合年成長率：2026-2031年 6.12%
成長最快的細分市場 製藥
最大的市場 北美洲

儘管前景光明，但該產業仍面臨一個重大障礙：實現規模化生產需要巨額資本投入。工業生物反應器建設的高昂初始成本使得生產商難以在價格上與傳統肉品競爭。這一資金壁壘有效地限制了產能的快速擴張，並阻礙了生產商滿足更廣泛的大眾市場需求。因此，最佳化生產經濟效益仍是限制整個產業發展的主要障礙。

市場促進因素

資本投資和策略聯盟的激增正在從根本上改變真菌蛋白產業，加速從試點規模運作向全面商業化生產的過渡。這筆資金的湧入對於克服建造生物反應器和開發下游基礎設施相關的巨額前期成本至關重要。例如，2024年1月，Infinite Roots宣布已獲得5,800萬美元的B輪資金籌措並擴大全球業務。這筆資金籌措將幫助企業提高生產效率並建立必要的供應鏈網路。此外，根據良好食品研究所（Good Food Institute）的一份報告，整個發酵資金籌措產業在上年度（2023年）共籌集了5.15億美元，凸顯了儘管經濟形勢普遍不明朗，投資者信心依然強勁。

肉類替代品和即食產品線的多元化是推動市場成長的重要因素，儘管它並非主要促進因素，但卻是其重要組成部分，這使得消費者更容易獲得真菌食品。製造商正積極在其產品線中添加全切產品和便捷的膳食解決方案，這些產品能夠忠實地複煞車物蛋白的質地和營養成分。這些產品在零售市場的普及對於將真菌蛋白從專業保健食品商店推廣到主流分銷管道至關重要。 Meati Foods 就是一個快速擴張的典型例子，該公司於 2024 年 4 月宣布，其產品已成功鋪貨至全美 6000 家零售店。這種策略性擴張凸顯了菌絲體產品的商業性可行性，並鼓勵零售商進一步採用，從而形成良性循環，進一步刺激產能和創新。

市場挑戰

擴大生產基礎設施所需的巨額資本投入是全球真菌蛋白市場成長的主要障礙。製造商在嘗試從試驗規模設施升級到供應大眾市場所需的工業生物反應器時，面臨著巨額的前期成本。這種財務負擔阻礙了企業降低單位成本，也使其無法實現規模經濟，因此無法達到與傳統動物性蛋白質相當的價格水準。因此，真菌蛋白產品的高價限制了其消費群體，進而阻礙了更廣泛的市場滲透和商業性可行性。

缺乏資金支持這些資本密集型項目，直接阻礙了該行業的擴張。根據良好食品研究所（Good Food Institute）的數據顯示，2024年全球發酵產業的私人投資總額約為6.51億美元。這筆資金體現了持續的投資興趣，但同時也表明，有限的資金池必須分配給整個產業的研發、營運和基礎設施建設。目前的投資水準不足以支持大規模建設商業規模的設施，而這些設施對於有效變革全球食品供應鏈至關重要。因此，生產商實際上無法達到大幅降低成本所需的產量，從而阻礙了市場的成長。

市場趨勢

全球真菌蛋白市場正經歷生產方式的變革，其驅動力在於循環經濟模式的普及，這種模式利用了升級再造的農業和工業原料。生產商正策略性地摒棄成本高昂的精製糖底物，轉而透過有效利用食品加工廢棄物等工業產品來培育高品質生質能。這種轉變顯著降低了營運成本，同時提高了原料的環境永續性。該方法的基材已得到證實，並促成了大規模基礎設施建設，旨在將低價值產品轉化為高品質蛋白質。芬蘭生技新創公司Enifer就是一個值得關注的例子。根據Green Queen在2024年5月報道，該公司在2024年成功資金籌措，並計劃建造一座專門用於利用食品工業產品生產真菌蛋白的商業設施。

同時，一種新型產品類型正在興起，即結合真菌和植物來源蛋白的混合配方，旨在滿足嚴格素食者和彈性素食者的需求。這些混合解決方案並非簡單地取代肉類；它們透過將菌絲體與動物性蛋白質或植物蛋白質結合，改善了產品的質地、保水性和營養密度。這種「肉+」策略利用真菌天然的纖維結構，更真實地模擬傳統肌肉組織的口感，從而克服了純植物來源替代品常見的質地缺陷。作為這一商業性方向的佐證，AgFunderNews在2024年1月報道稱，Mush Foods已在美國正式推出其「50CUT」菌絲體混合物。該產品旨在牛牛肉產品中的動物肉比例降低50%，同時保持其原始風味。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球真菌蛋白市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（酵母、Fusarium v​​ienatum）
    • 按性質（有機、常規）
    • 按應用領域（食品飲料、動物飼料、藥品、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美真菌蛋白市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲真菌蛋白市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區真菌蛋白市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲真菌蛋白市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲真菌蛋白市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球真菌蛋白市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Cayman Chemical Company
  • CHIHONBIO CO., LTD.
  • Duke Thomson's India Pvt. Ltd
  • DuPont de Nemours, Inc.
  • Virgin Galactic Holdings Inc
  • Mayasan Gida Sanayi ve Ticaret AS
  • Merck KGaA
  • dsm-firmenich AG
  • Santa Cruz Biotechnology, Inc
  • Siveele BV

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 20679

The Global Fungal Protein Market is projected to expand significantly, rising from USD 4.11 Billion in 2025 to USD 5.87 Billion by 2031, demonstrating a compound annual growth rate of 6.12%. Fungal protein, a sustainable food ingredient, is produced through the fermentation of fungi like Fusarium venenatum, yielding fibrous alternatives to meat. This market expansion is primarily fueled by the critical global demand for resource-efficient food systems and a growing consumer preference for ethically sourced, animal-free proteins. These factors represent enduring, structural shifts within the global food supply rather than transient market fads. For instance, data from the Good Food Institute indicates that approximately 50% of French consumers in 2025 were receptive to products derived from precision fermentation, underscoring the category's expanding commercial promise.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 4.11 Billion
Market Size 2031USD 5.87 Billion
CAGR 2026-20316.12%
Fastest Growing SegmentPharmaceuticals
Largest MarketNorth America

Despite this promising outlook, the sector faces a substantial hurdle in the form of high capital investment necessary for achieving scalability. The construction of industrial bioreactors entails considerable upfront expenses, preventing manufacturers from achieving price competitiveness with conventional meat products. This financial barrier effectively constrains rapid production capacity expansion and hinders producers' ability to cater to the broader mass market. Consequently, optimizing production economics remains a formidable impediment to the industry's widespread growth.

Market Driver

Surging capital investments and strategic alliances are fundamentally transforming the fungal protein sector, facilitating its transition from pilot-scale operations to full commercial production. These financial inflows are crucial for overcoming the substantial initial costs associated with constructing bioreactors and establishing downstream processing infrastructure. For example, Infinite Roots announced in January 2024 that it secured $58 million in Series B financing, specifically to scale its mycelium fermentation technologies and broaden its global reach. This funding enables companies to refine production efficiencies and build essential supply chain networks. Furthermore, the Good Food Institute reported that the wider fermentation-enabled protein sector attracted $515 million in capital funding during the preceding year (2023), highlighting sustained investor confidence despite broader economic instability.

A secondary yet potent catalyst for market growth is the increasing diversification of meat alternative and ready-to-eat product portfolios, which directly enhances consumer access to fungal-based foods. Manufacturers are proactively expanding their product lines to include whole-cut analogs and convenient meal solutions that accurately replicate the texture and nutritional profile of animal proteins. This proliferation in retail is vital for transitioning fungal proteins from specialized health food outlets to mainstream distribution channels. An illustrative example of this rapid distribution growth is Meati Foods, which in April 2024 announced a successful expansion of its product availability to 6,000 retail locations across the United States. Such strategic expansions validate the commercial viability of mycelium products and encourage greater retailer adoption, thereby creating a positive feedback loop that stimulates further production capacity and innovation.

Market Challenge

The substantial capital investment required to scale production infrastructure represents a significant impediment to the growth of the Global Fungal Protein Market. Manufacturers encounter immense upfront costs when attempting to upgrade from pilot-scale facilities to industrial-grade bioreactors, which are essential for supplying mass-market volumes. This financial burden prevents companies from achieving the necessary economies of scale to reduce unit costs and attain price parity with traditional animal proteins. As a result, the elevated price point of fungal protein products restricts their adoption to a limited consumer segment, thereby impeding broader market penetration and commercial viability.

The insufficient funding available to support these capital-intensive projects directly slows the industry's expansion. According to the Good Food Institute, the global fermentation sector attracted approximately $651 million in total private funding in 2024. While this sum indicates ongoing interest, it represents a finite pool of capital that must be allocated across research, operations, and infrastructure throughout the entire industry. This level of investment is currently inadequate to finance the widespread construction of commercial-scale facilities needed to effectively disrupt the global food supply chain. Consequently, the market's growth trajectory is hindered by producers' physical inability to generate the volumes required to trigger critical cost reductions.

Market Trends

The Global Fungal Protein Market is experiencing a transformation in production methodologies through the adoption of circular economy models that utilize upcycled agro-industrial feedstocks. Producers are strategically moving away from costly, refined sugar substrates, instead valorizing industrial sidestreams, such as food processing waste, to cultivate high-quality biomass. This shift significantly lowers operational expenditures while simultaneously enhancing the environmental sustainability of their ingredients. The proven feasibility of this approach is driving considerable infrastructure development focused on converting low-value byproducts into premium protein. A notable example is the Finnish biotech startup Enifer, which, as reported by Green Queen in May 2024, secured total financing of €36 million in 2024 to construct a commercial facility specifically designed to produce mycoprotein from food industry sidestreams.

Concurrently, a new product category is emerging with the development of hybrid fungal and plant-based protein formulations, designed to cater to both strict vegetarians and flexitarians. Rather than solely replacing meat, these hybrid solutions integrate mycelium with animal proteins or plant bases to improve texture, moisture retention, and nutritional density. This "meat-plus" strategy addresses common sensory shortcomings found in pure plant-based alternatives by leveraging fungi's natural fibrous structure to better mimic the mouthfeel of conventional muscle tissue. Highlighting this commercial direction, AgFunderNews reported in January 2024 that Mush Foods commercially launched its 50CUT mycelium blends in the United States, which are engineered to reduce the animal meat content in ground beef products by 50% while fully preserving flavor integrity.

Key Market Players

  • Cayman Chemical Company
  • CHIHONBIO CO., LTD.
  • Duke Thomson's India Pvt. Ltd
  • DuPont de Nemours, Inc.
  • Virgin Galactic Holdings Inc
  • Mayasan Gida Sanayi ve Ticaret A.S
  • Merck KGaA
  • dsm-firmenich AG
  • Santa Cruz Biotechnology, Inc
  • Siveele B.V.

Report Scope

In this report, the Global Fungal Protein Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fungal Protein Market, By Type

  • Yeast
  • Fusarium Venenatum

Fungal Protein Market, By Nature

  • Organic
  • Conventional

Fungal Protein Market, By Application

  • Food and beverages
  • Animal Nutrition
  • Pharmaceuticals
  • Others

Fungal Protein Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Fungal Protein Market.

Available Customizations:

Global Fungal Protein Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Fungal Protein Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Yeast, Fusarium Venenatum)
    • 5.2.2. By Nature (Organic, Conventional)
    • 5.2.3. By Application (Food and beverages, Animal Nutrition, Pharmaceuticals, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Fungal Protein Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Nature
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Fungal Protein Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Nature
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Fungal Protein Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Nature
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Fungal Protein Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Nature
        • 6.3.3.2.3. By Application

7. Europe Fungal Protein Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Nature
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Fungal Protein Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Nature
        • 7.3.1.2.3. By Application
    • 7.3.2. France Fungal Protein Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Nature
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Fungal Protein Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Nature
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Fungal Protein Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Nature
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Fungal Protein Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Nature
        • 7.3.5.2.3. By Application

8. Asia Pacific Fungal Protein Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Nature
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Fungal Protein Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Nature
        • 8.3.1.2.3. By Application
    • 8.3.2. India Fungal Protein Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Nature
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Fungal Protein Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Nature
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Fungal Protein Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Nature
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Fungal Protein Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Nature
        • 8.3.5.2.3. By Application

9. Middle East & Africa Fungal Protein Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Nature
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Fungal Protein Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Nature
        • 9.3.1.2.3. By Application
    • 9.3.2. UAE Fungal Protein Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Nature
        • 9.3.2.2.3. By Application
    • 9.3.3. South Africa Fungal Protein Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Nature
        • 9.3.3.2.3. By Application

10. South America Fungal Protein Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Nature
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Fungal Protein Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Nature
        • 10.3.1.2.3. By Application
    • 10.3.2. Colombia Fungal Protein Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Nature
        • 10.3.2.2.3. By Application
    • 10.3.3. Argentina Fungal Protein Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Nature
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Fungal Protein Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Cayman Chemical Company
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. CHIHONBIO CO., LTD.
  • 15.3. Duke Thomson's India Pvt. Ltd
  • 15.4. DuPont de Nemours, Inc.
  • 15.5. Virgin Galactic Holdings Inc
  • 15.6. Mayasan Gida Sanayi ve Ticaret A.S
  • 15.7. Merck KGaA
  • 15.8. dsm-firmenich AG
  • 15.9. Santa Cruz Biotechnology, Inc
  • 15.10. Siveele B.V.

16. Strategic Recommendations

17. About Us & Disclaimer